Synapsyl, a dietary supplement from the French laboratory NHCO, is formulated for nerve balance and stress management. Its composition combines amino acids, adaptogenic plants, and micronutrients. But what are the real risks associated with this product, especially in cases of medication treatment or specific conditions? The available data allows for the identification of several points of caution that are rarely detailed in standard product sheets.
Drug Interactions of Synapsyl: What the Composition Implies
The formula of Synapsyl contains L-theanine, rhodiola, and magnesium, three active ingredients that act on the central nervous system. Taken individually, each has a correct tolerance profile in healthy adults.
The problem arises when combined with psychotropic treatments. Recent pharmacological reviews on L-theanine show additive or synergistic anxiolytic effects with benzodiazepines (lorazepam, diazepam, alprazolam). The main risk: an increase in drowsiness and a decrease in alertness, potentially dangerous while driving or in a demanding professional context.
A French pharmacy (Pharmacie du Stade Vélodrome, Marseille) specifies in its updated usage advice from August 2026 that Synapsyl should be “avoided in case of concomitant use of antidepressants or sedatives without prior medical advice.” This mention, absent from most marketing pages, indicates a risk of increased sedation that must be taken seriously.
Several sources also document that the side effects of Synapsyl are underestimated in commercial sheets, which focus on benefits without detailing precautions related to combinations.
Synapsyl and Digestive or Neurological Side Effects: Reported Signal Table
User feedback and online pharmacy notices allow for the creation of a table of side effects associated with the main active ingredients of the Synapsyl formula.
| Active Ingredient | Possible Side Effect | At-Risk Population |
|---|---|---|
| L-theanine | Drowsiness, decreased alertness | People on sedatives or benzodiazepines |
| Rhodiola | irritability, insomnia (at high doses) | People sensitive to stimulants |
| Magnesium (high dose) | Digestive disorders (diarrhea, cramps) | People with sensitive transit |
| Saffron (extract) | Potential interaction with SSRIs (antidepressants) | Patients on Lexapro, Prozac, or equivalents |
This table shows that effects vary significantly depending on the user’s profile. An adult without treatment and without digestive pathology is unlikely to notice anything. In contrast, a person on an SSRI antidepressant who adds Synapsyl to their routine exposes themselves to a cumulative effect of serotonergic effects whose consequences are not trivial.
Rhodiola and Saffron in Synapsyl: Two Double-Edged Plants
Rhodiola rosea is classified among adaptogenic plants. Its inclusion in Synapsyl aims at stress resistance. Pharmacological data indicate that this plant can, at high doses or in certain profiles, cause irritability or sleep disturbances, which is the opposite of the desired effect.
Saffron, another component of the formula, has received particular attention in recent literature. Specialized publications report a potential interaction between saffron extract and SSRIs such as Lexapro (escitalopram). The mechanism at play: saffron also acts on serotonergic pathways, which can amplify the effect of the antidepressant and increase the risk of serotonin syndrome (agitation, tachycardia, hyperthermia).
These interactions do not appear on the Synapsyl packaging. Since the product is not a medication but a dietary supplement, it is not subject to the same pharmacovigilance obligations. It is precisely this gray area that makes prior medical consultation necessary.
Populations for Whom Synapsyl is Not Recommended
Regulatory mentions and pharmacy notices identify several categories of people who should avoid this supplement without medical advice:
- Pregnant or breastfeeding women, as a precaution related to adaptogenic plants and neuroactive amino acids
- People on antidepressant treatment (SSRIs, tricyclics) or anxiolytics (benzodiazepines), due to the risk of additive effects on sedation or serotonin
- People on sedative or hypnotic treatment, as L-theanine can enhance drowsiness
- Individuals with hypersensitivity to any of the components of the formula
Dietary Supplement and Information Obligation: The Regulatory Status of Synapsyl
Synapsyl is not a medication. It is marketed as a dietary supplement intended for nerve balance. This distinction has a direct consequence: the product does not go through the market authorization procedures (AMM) of the ANSM. Manufacturers are not required to provide a notice detailing drug interactions in the same way as a pharmaceutical laboratory.
The NHCO laboratory, based in France and active since 2008, markets Synapsyl in capsule form. The formula highlights the nutritional reference values (NRV) for magnesium and B vitamins. This data is reassuring, but it does not cover the issue of cross-interactions with other active substances.
The difference between a medication and a dietary supplement also lies in the reporting of adverse effects. For a medication, the pharmacovigilance circuit is structured. For a supplement, reporting largely relies on the individual initiative of the consumer or healthcare professional, leading to systematic underreporting.
Before incorporating Synapsyl into a daily routine, the most reliable approach remains consulting a doctor or pharmacist, especially in cases of ongoing treatment. The potential benefits for stress and emotional balance do not exempt one from an evaluation of the risks specific to each situation.